A patient on lithium 900 mg daily has a serum lithium level of 1.7 mmol/L; what is the appropriate management?

Immediate Management of Lithium Level 1.7 mmol/L

Stop lithium immediately and check renal function, electrolytes, and clinical signs of toxicity—this level exceeds the therapeutic range and approaches the toxic threshold where serious adverse effects can occur. 1

Understanding the Severity

A lithium level of 1.7 mmol/L is significantly elevated and requires urgent intervention. The FDA label explicitly states that "lithium toxicity is closely related to serum lithium levels, and can occur at doses close to therapeutic levels" 1. While the acute treatment range extends to 1.5 mmol/L 1, your patient's level of 1.7 mmol/L exceeds even this upper limit and approaches the range where patients commonly exhibit toxic signs (1.5-2.0 mmol/L range).

Immediate Actions Required

1. Discontinue Lithium

• Hold all lithium doses immediately
• Do not resume until level drops to safe range and clinical assessment is complete

2. Assess for Toxicity Signs

Look specifically for:

• Neurological: tremor (coarse, not fine), confusion, ataxia, slurred speech, hyperreflexia, seizures
• Gastrointestinal: nausea, vomiting, diarrhea
• Cardiac: bradycardia, T-wave changes, AV block 2
• Renal: polyuria, polydipsia (nephrogenic diabetes insipidus) 1

3. Laboratory Workup

• Repeat lithium level in 12-24 hours to confirm trend
• Renal function: serum creatinine, BUN, creatinine clearance
• Electrolytes: particularly sodium (hyponatremia increases lithium retention)
• ECG: to assess for cardiac conduction abnormalities 2

4. Identify Contributing Factors

Investigate potential causes of elevation:

• Drug interactions: NSAIDs, diuretics, ACE inhibitors, antibiotics (particularly common) 3
• Dehydration or sodium depletion 1
• Renal impairment (lithium clearance decreases with age and kidney disease) 1
• Recent dose increase or irregular dosing pattern 3

When to Resume Lithium

Do not restart lithium until:

• Level drops below 1.0 mmol/L (ideally to 0.6-0.8 mmol/L range)
• All signs of toxicity have resolved
• Contributing factors have been identified and addressed
• Renal function is stable

Dosing Adjustment Upon Restart

When restarting, reduce the dose substantially:

• If no clear precipitant was found: reduce daily dose by at least 300-450 mg
• If drug interaction or dehydration identified: may restart at same dose once precipitant removed, but monitor closely
• Target therapeutic range for maintenance is 0.6-0.8 mmol/L 4, 5—not higher
• Check level 5-7 days after restart, then weekly until stable

Critical Pitfalls to Avoid

1. Do not continue lithium "at a lower dose" while level is 1.7 mmol/L—complete cessation is required
2. Do not assume the patient is asymptomatic—subtle neurotoxicity may be present and can progress
3. Do not overlook drug interactions, especially recent antibiotic prescriptions 3
4. Do not restart at the same 900 mg dose without identifying why the level rose
5. Elderly patients are particularly vulnerable—they often exhibit toxicity at levels tolerated by younger patients 1 and may require permanently lower maintenance doses

Monitoring After Resolution

Once restarted and stabilized:

• Check lithium level weekly for 3-4 weeks
• Then every 3 months if stable 6
• Monitor renal function every 6-12 months 1
• Maintain levels in the 0.6-0.8 mmol/L range for maintenance therapy 4, 5

The evidence consistently shows that levels above 1.5 mmol/L carry significant risk, and your patient at 1.7 mmol/L requires immediate action to prevent progression to severe toxicity with potential permanent neurological or renal sequelae.